Live Chat

Negocie Vir Biotechnology VIR

Venda
 Comprar

Gráfico VirBiotechnology ao vivo

5m 15m 30m 1h 4h 1d 1w

Fundamentos do instrumento

Weekly Search
Weekly
Daily
Data Fechar Mudança Alteração (%): Abertura Max Min

Info

Spread

0.05

Spread (%)

0.6562 %

Alavancagem

1:10

Juro overnight, Compra

-0.0597 %

Juro overnight, Venda

-0.0292 %

Moeda

USD

Horários de Negociação

Mercados fechados

Segunda-feira

13:31 - 19:59

Terça-feira

13:31-19:59

Quarta-feira

13:31-19:59

Quinta-feira

13:31-19:59

Sexta-feira

13:31-19:59

Análise e estatística

Abertura

---

Fechamento anterior

---

Alta/baixa em 52 semanas

--- – ---

Capitalização de mercado

1317845888

Ações em circulação

136706000

Data dos rendimentos (Próxima)

0000-00-00

Rendim Divid

Data Ex-Dividendos

Taxa anual futura de dividendos

0

Rendimento anual futuro de dividendos

0

EPS

-3.58

Saiba mais sobre este instrumento

Vir Biotechnology Vir Biotechnology Inc
Vir Biotechnology, Inc., an immunology company, develops therapeutic products to treat and prevent serious infectious diseases. Its clinical development pipeline consists of product candidates targeting hepatitis delta virus (HDV), hepatitis B virus (HBV), and human immunodeficiency virus (HIV). The company's preclinical candidates include those targeting influenza A and B, coronavirus disease 2019, respiratory syncytial virus (RSV) and human metapneumovirus (MPV), and human papillomavirus (HPV). The company has grant agreements with Bill & Melinda Gates Foundation and National Institutes of Health; an option and license agreement with Brii Biosciences Limited; a collaboration and license agreement with Alnylam Pharmaceuticals, Inc.; license agreements with MedImmune, LLC; collaboration with WuXi Biologics (Hong Kong) Limited and Glaxo Wellcome UK Ltd.; and a collaborative research agreement with GlaxoSmithKline Biologicals S.A, as well as license agreement with Sanofi for three clinical-stage masked T-cell engagers (TCEs) and exclusive use of the protease-cleavable masking platform for oncology and infectious diseases. It also has a manufacturing agreement with Samsung Biologics Co.,Ltd. The company was incorporated in 2016 and is headquartered in San Francisco, California.

Instrumentos relacionados

Ativo
Venda
Comprar
Alteração (%):

Negociar agora

Negociar agora

Negociar agora

Negociar agora
Instrumentos relacionados

Últimas notícias

Fique em dia com as últimas notícias financeiras pelo mundo afora.

Quarta-feira, 6 Novembro 2024

U.S. presidential election market volatility drives Bitcoin prices to reach a historic high

Stock market rally

Terça-feira, 5 Novembro 2024

US Election Results Trigger Stock Gains Across Europe, Asia, and US

US Election Trump's victory

Terça-feira, 5 Novembro 2024

Trump Victory Spurs Market Gains and Economic Shift Expectations

Terça-feira, 5 Novembro 2024

US election: bitcoin price (BTC) surged to new record as Trump leading ahead

Terça-feira, 5 Novembro 2024

Stock Market Today: Wall Street Rallies on Election Day Amid Strong Economic Outlook

US Election 2024 Trump

Terça-feira, 5 Novembro 2024

Early Election Results Shift Markets as Trump’s Chances Rise

Segunda-feira, 4 Novembro 2024

Stock Market Today: S&P 500 Declines as Investors Brace for US Election

Segunda-feira, 4 Novembro 2024

US election: What will happen to tesla stock if Trump wins?

Ver todas as notícias
Trustpilot
Live Chat